4D Molecular Therapeutics Inc

-1.38 (-3.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)969.03M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.56 Million
Adjusted EPS-$0.83
See more estimates
10-Day MA$37.75
50-Day MA$43.21
200-Day MAN/A
See more pivots

4D Molecular Therapeutics, Inc. Stock, NASDAQ:FDMT

5858 Horton Street, Suite 455, Emeryville, California 94608
United States of America
Phone: +1.510.505.2680
Number of Employees:


4D Molecular Therapeutics, Inc. designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. It offers lysosomal storage disease, lung disease, muscular dystrophy, and ophthalmological disease services. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer in 2013 and is headquartered in Emeryville, CA.